FDA Panel Rejects Avastin for Breast Cancer:
It's expensive
Medical News Today
Expert Summary
Even without FDA approval, the cost of Avastin could be prohibitive for women who want to use it to slow the growth of their breast cancers. Is it worth $100,000 a year?
Deanna Durica
Expert Scorecard
Overall Expert Score
Community Reviews
Overall Community Rating:
(0 reviews)
Add your rating:
click to select